IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 982 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Prevalence and predictors of potential drug–drug interactions in patients of internal medicine wards of a tertiary care hospital in India
Yugandhar Bethi,Deepak Gopal Shewade,Tarun Kumar Dutta,Batmanabane Gitanjali
European Journal of Hospital Pharmacy.2018;25(6)317
[DOI]
2Assessing Drug-Drug Interaction Potential among Patients Admitted to Surgery Departments in Three Palestinian Hospitals
Abdullah K. Rabba,Ayeshe M. Abu Hussein,Bayan K. Abu Sbeih,Somaya I. Nasser
BioMed Research International.2020;2020(6)1
[DOI]
3Reintroduction of Post-Baccalaureate Doctor of Pharmacy (PharmD, Post-Bac) Program in Nepal: Exploration of the Obstacles and Solutions to Move Forward
Sunil Shrestha,Sweta Shrestha,Binaya Sapkota,Rajani Shakya,Rohullah Roien,Mohamed Izham Mohamed Ibrahim
Advances in Medical Education and Practice.2022;Volume 13(6)159
[DOI]
4A PROSPECTIVE OBSERVATIONAL STUDY ON THE ASSESSMENT OF POTENTIAL DRUG-DRUG INTERACTIONS AND MANAGEMENT OF POST-COMPLICATIONS IN STROKE PATIENTS AT A TERTIARY CARE TEACHING HOSPITAL
MAHE NAAZ SULTANA,SABA YOUNUS QURESHI,IQRA FATIMA,WAJIDA JABEEN,MOHAMMED OBAID
International Journal of Pharmacy and Pharmaceutical Sciences.2021;Volume 13(6)8
[DOI]
5A PROSPECTIVE OBSERVATIONAL STUDY ON THE ASSESSMENT OF POTENTIAL DRUG-DRUG INTERACTIONS AND MANAGEMENT OF POST-COMPLICATIONS IN STROKE PATIENTS AT A TERTIARY CARE TEACHING HOSPITAL
Subish Palaian
International Journal of Pharmacy and Pharmaceutical Sciences.2020;Volume 13(6)335
[DOI]
6Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency
Pengqiang Du,Aifeng Wang,Yongcheng Ma,Ao Jia,Yafei Li,Xingang Li
Clinical Therapeutics.2020;42(9)1799
[DOI]
7Involvement of pregnane X receptor in the suppression of carboxylesterases by metformin in vivo and in vitro, mediated by the activation of AMPK and JNK signaling pathway
Enfang Shan,Zhu Zhu,Shuangcheng He,Dongbao Chu,Dinghao Ge,Yunran Zhan,Wei Liu,Jian Yang,Jing Xiong
European Journal of Pharmaceutical Sciences.2017;102(9)14
[DOI]
8Potential drug–drug interactions and associated factors among hospitalized cardiac patients at Jimma University Medical Center, Southwest Ethiopia
Netsanet Diksis,Tsegaye Melaku,Desta Assefa,Andualem Tesfaye
SAGE Open Medicine.2019;7(9)205031211985735
[DOI]
9Drug–drug interactions in patients with acute coronary syndrome across phases of treatment
Ana V. Pejcic,Slobodan M. Jankovic,Goran Davidovic
Internal and Emergency Medicine.2019;14(3)411
[DOI]
10

Clinical Pharmacy Education and Practice in Nepal: A Glimpse into Present Challenges and Potential Solutions

Sunil Shrestha,Deepa Shakya,Subish Palaian
Advances in Medical Education and Practice.2020;Volume 11(3)541
[DOI]
11Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study
Zarka Akbar,Sundas Rehman,Asad Khan,Amjad Khan,Muhammad Atif,Nafees Ahmad
Journal of Pharmaceutical Policy and Practice.2021;14(1)541
[DOI]
12Drug scheduling by nurses and drug interactions in patients with cardiovascular diseases
Natália da Palma Sobrinho,Juliana Faria Campos,Rafael Celestino da Silva
Revista Brasileira de Enfermagem.2020;73(5)541
[DOI]
13Prevalence and characteristics of drug-drug interactions among hospitalised patients in the Capital Region of Denmark
Hans Kristian Råket Pedersen,Anne Mette Skov Sørensen,Astrid Blicher Schelde,Martin Erik Nyeland,Espen Jimenez-Solem
Adverse Drug Reaction Bulletin.2021;Publish Ahead of Print(5)541
[DOI]
14Prevalencia de potenciales interacciones farmacológicas de Azitromicina en Colombia, 2012-2013
Jorge Enrique Machado Alba,Dayron Martinez,Daniela Gomez-Suta
Revista de Salud Pública.2015;17(3)463
[DOI]
15The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients
Kaloyan D. Georgiev,Nadezhda Hvarchanova,Marieta Georgieva,Branimir Kanazirev
International Journal of Clinical Pharmacy.2019;41(6)1555
[DOI]
16Data Sharing and Privacy in Pharmaceutical Studies
Rufan Chen,Yi Zhang,Zuochao Dou,Feng Chen,Kang Xie,Shuang Wang
Current Pharmaceutical Design.2021;27(7)911
[DOI]
17Assessment of potential drug–drug interactions and its associated factors in the hospitalized cardiac patients
Ghulam Murtaza,Muhammad Yasir Ghani Khan,Saira Azhar,Shujaat Ali Khan,Tahir M. Khan
Saudi Pharmaceutical Journal.2016;24(2)220
[DOI]
18A Prospective Analysis of Potential and Observed Drug-Drug Interactions, Adverse Events and its Associated Risk Factors in Hospitalized Cardiology Patients in Benin
Aurel C.E. Allabi,Yessoufou Tchabi,Murielle Hounkponou,Rebecca Quenum,Jeanne Vehounkpe-Sacca
Current Drug Safety.2020;15(3)190
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow